Cardiovascular Business July 25, 2024
Businesses in the cardiovascular health space have busy in recent weeks, announcing one big financing round after another. Magenta Medical just raised $105 million to help secure U.S. Food and Drug Administration (FDA) approval for its new heart pump, for example, while Adona Medical brought in $33.5 million to go toward product development and getting its new technology in the hands of physicians.
These are some other big-dollar funding stories from the past several days:
Cardurion Pharmaceuticals raises $260M to help push new therapies forward
Cardurion Pharmaceuticals, a Massachusetts-based biotech company, closed a Series B financing round worth $260 million. Ascenta Capital led the round, with additional investments coming from NEA, GV, Fidelity Management & Research Company, Millennium Management, Farallon...